114 related articles for article (PubMed ID: 4612715)
1. [Value of a pharmaceutic preparation combining benziodarone with an alkalinizator for the treatment of gout].
André LJ; Delprat J
Sem Hop Ther; 1974; 50(5-6):376-80. PubMed ID: 4612715
[No Abstract] [Full Text] [Related]
2. [A new medicine for gout ailments: benziodarone].
Deshayes P; Cardinael Y
Rhumatologie; 1967; 19(7):255-8. PubMed ID: 5619724
[No Abstract] [Full Text] [Related]
3. [Gout and benziodarone].
Thomas J
Rein Foie; 1967; 10():249-60. PubMed ID: 6081452
[No Abstract] [Full Text] [Related]
4. [Benziodarone in the treatment of primary hyperuricemias].
Bianco G; Marcolongo R; Carcassi A
Minerva Med; 1968 Dec; 59(99):5470-81. PubMed ID: 5718835
[No Abstract] [Full Text] [Related]
5. [Benziodarone in the basic treatment of gout].
Ryckewaert A; Puel M; Kuntz D
Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
[No Abstract] [Full Text] [Related]
6. [Treatment of hyperuricemia with benziodarone].
Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
[No Abstract] [Full Text] [Related]
7. An evidence based appraisal of the management of nontophaceous interval gout.
Ferraz MB
J Rheumatol; 1995 Sep; 22(9):1618-9. PubMed ID: 8523332
[No Abstract] [Full Text] [Related]
8. [Effect of benziodarone on hyperuricemia due to fasting].
Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
[No Abstract] [Full Text] [Related]
9. [Hyperuricemia and benziodarone].
Haddad N; Zamouri A; Naccache S
Tunis Med; 1973; 51(2):103-4. PubMed ID: 4784400
[No Abstract] [Full Text] [Related]
10. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
Mugler A
Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
[No Abstract] [Full Text] [Related]
11. Gout: its causes, symptoms and treatment.
Hill J
Nurs Times; 1999 Nov 24-Dec 1; 95(47):48-50. PubMed ID: 11096905
[No Abstract] [Full Text] [Related]
12. [Choice between uricosurics and inhibitors of uric acid synthesis in the treatment of gout].
Kono H; Yonezawa H; Naito H
Nihon Rinsho; 1975 Feb; 33(2):356-60. PubMed ID: 1170378
[No Abstract] [Full Text] [Related]
13. [Uricosuric and anti-gout action of certain benzofuran derivatives].
Delbarre F; Auscher C; Amor B
Presse Med (1893); 1965 Nov; 73(48):2725-6. PubMed ID: 5842108
[No Abstract] [Full Text] [Related]
14. [Treatment of hyperuricemia and gout].
Gröbner W; Walter-Sack I
Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
[No Abstract] [Full Text] [Related]
15. [The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].
Lindusková M; Vykydal M
Cas Lek Cesk; 1990 Nov; 129(48):1524-5. PubMed ID: 2257602
[TBL] [Abstract][Full Text] [Related]
16. [Benziodarone in gout therapy].
Ryckewaert A; Kuntz D
Therapeutique; 1970 Dec; 46(10):989-91. PubMed ID: 5511935
[No Abstract] [Full Text] [Related]
17. Progress in the pharmacotherapy of gout.
Sundy JS
Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
[TBL] [Abstract][Full Text] [Related]
18. [Gout treatment with a dibromine derivative of benzofuran].
Delbarre F; Auscher C; Saporta L; de Grey A; Danchot J
Rev Rhum Mal Osteoartic; 1973 Apr; 40(4):275-7. PubMed ID: 4716906
[No Abstract] [Full Text] [Related]
19. [Benzodiarone in the therapy of gout].
Chériè Lignière G; Solazzi F
Reumatismo; 1968; 20(1):53-62. PubMed ID: 5708869
[No Abstract] [Full Text] [Related]
20. [Clinical and biological action of a new hypouricemiant (benziodarone) in gout. Results of 2 years of experience].
Santamaría A; Barceló P
Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):252-63. PubMed ID: 4899417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
